In infections, large bacterial loads—such as those found in abscesses or biofilm-covered surfaces—often display reduced susceptibility to host AMPs or AMP-based therapeutics, requiring higher doses or combination strategies for effective clearance. The gene discussed is ADSL; the disease is infection.